Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Chiquita Brands International Inc. (NYSE: CQB) shares spiked 6.10 percent to close at $10.79 a share Monday. The stock traded between $10.26 and $11.19 on volume of 833,481 shares traded. Analysts at BB&T Capital have recently upgraded the company’s rating to “buy” from “hold”. Shares of Chiquita Brands have gained approximately 30.8 percent year-to-date.
Find out more about Chiquita Brands including full access to the free equity report at:
Giant Interactive Group Inc. (NYSE: GA) shares declined 7.08 percent to close at $7.09 a share Monday. The stock traded in between $6.85 and $7.50 on volume of 1.55 million shares traded. Chinese Equities were dragged down by a 5.3 percent drop in the Shanghai Composite Index. Shares of Giant Interactive Group have gained approximately 31.0 percent year-to-date.
Find out more about Giant Interactive Group including full access to the free equity report at:
Halozyme Therapeutics, Inc. (NASDAQ: HALO) shares spiked 8.70 percent to close at $6.68 a share Monday. The stock traded between $5.88 and $6.88 on volume of 2.72 million shares traded. The company earlier this month reported results from a Phase 1b trial of PEGPH20 with gemcitabine which indicated positive activity against pancreatic cancer. Shares of Halozyme Therapeutics have fallen approximately 9.9 percent in the past month.
Find out more about Halozyme Therapeutics including full access to the free equity report at:
Warner Chilcott Plc (NASDAQ: WCRX) shares declined 1.76 percent to close at $18.94 a share Monday. The stock traded in between $18.74 and $19.24 on volume of 3.39 million shares traded. Analysts at Jefferies have recently downgraded the company’s rating to “hold” from “buy”. Shares of Warner Chilcott have gained approximately 57.3 percent year-to-date.
Find out more about Warner Chilcott including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing